Keyphrases
Clinical Features
100%
CT-based
100%
Radiomics
100%
Radiomics Model
100%
High-grade Prostate Cancer
100%
Radiotherapy
57%
Prostate
57%
Prostate Cancer Patients
57%
Progression-free Survival
57%
Area under the Curve
57%
Planning Computed Tomography
42%
Validation Cohort
42%
Clinical Characteristics
28%
Gross Tumor Volume
28%
Combined Model
28%
Hong Kong
14%
Tumor
14%
Serum Concentration
14%
Clinical Data
14%
Classification Performance
14%
Root Mean Square
14%
Model Comparison
14%
Clinical Factors
14%
Classification Model
14%
At-risk
14%
R-model
14%
Receiver Operating Characteristic Curve
14%
Vulnerable Subgroups
14%
Disease Progression
14%
Ridge Regression
14%
CS Model
14%
Roach
14%
Patient Cohort
14%
Filtered Images
14%
Precision Medicine
14%
Clinical Model
14%
Training Population
14%
Prognostic Value
14%
Princess
14%
Personalized Treatment
14%
Toxicity Profile
14%
Prostate-specific Antigen
14%
Free Group
14%
Laplacian of Gaussian
14%
Feature Attribute
14%
5-fold Cross Validation
14%
Laplacian of Gaussian Filter
14%
Predictive Features
14%
Pretreatment Planning
14%
Progression-free
14%
Precision-recall Curve
14%
Whole Pelvic Radiotherapy
14%
Gleason Score
14%
Medicine and Dentistry
Radiomics
100%
Prostate Cancer
100%
Clinical Feature
100%
Prognostication
100%
Progression Free Survival
62%
Radiation Therapy
50%
Neoplasm
37%
Computer Assisted Tomography
37%
Disease Exacerbation
12%
Treatment Planning
12%
Personalized Medicine
12%
Prostate Specific Antigen
12%
Cross-Validation
12%
Clinician
12%
Pelvic Radiotherapy
12%
Gleason Score
12%
Biopsy Technique
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Clinical Feature
100%
Progression Free Survival
83%
Neoplasm
50%
Cross-Validation
16%
Disease Exacerbation
16%
Prostate Specific Antigen
16%
Gleason Score
16%
Immunology and Microbiology
Prostate
100%
Progression Free Survival
100%
Computer Assisted Tomography
60%
Gross Tumor Volume
40%
Gleason Score
20%
Blood Level
20%
Prostate Specific Antigen
20%
Pelvis
20%
Biochemistry, Genetics and Molecular Biology
Radiomics
100%
Progression Free Survival
62%
Computer Assisted Tomography
37%
Gaussian Distribution
25%
Gross Tumor Volume
25%
Blood Level
12%
Gleason Score
12%
Prostate-Specific Antigen
12%